Physician profile
Benjamin Meeks
NPI 1821025222
$2,526.54
in general payments reported to CMS, 2019-2025
19 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $387 · 2021: $459 · 2022: $481 · 2023: $327 · 2024: $210 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $608.65 | 2021-2023 | Xtampza, Belbuca |
| Scilex Pharmaceuticals INC. | $497.87 | 2019-2024 | Ztlido |
| Biodelivery Sciences International, INC. | $388.14 | 2019-2021 | |
| Medtronic, INC. | $266.64 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Globus Medical, INC. | $186.36 | 2025 | Omnia, Senza |
| Abbott Laboratories | $170.39 | 2022-2023 | Proclaim |
| Boston Scientific Corporation | $145.44 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Arbor Pharmaceuticals, INC. | $43.59 | 2022 | |
| Curonix LLC | $35.16 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $32.97 | 2023-2024 | Senza |
| Pfizer INC. | $25.84 | 2021 | |
| Abbvie INC. | $18.02 | 2022 | |
| Allergan, INC. | $17.71 | 2021 | |
| Nalu Medical, INC. | $17.13 | 2021 | |
| Tersera Therapeutics LLC | $15.37 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $14.67 | 2021 | |
| Ibsa Pharma INC. | $14.49 | 2024 | Tirosint, Licart |
| Amneal Pharmaceuticals LLC | $14.38 | 2022 | |
| Grt US Holding, INC. | $13.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Meeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.